Usefulness of FDG-microPET for early evaluation of therapeutic effects on VX2 rabbit carcinoma
Tóm tắt
The aim of this study was to determine the potential use of high-resolution FDG-microPET for predicting the primary effects of radiotherapy and/or hyperthermia on tumor-bearing rabbits. Twenty-eight VX2 xenografts in the thighs of rabbits were divided into the following 5 treatment groups: radiotherapy at a single dose of 10, 20 or 30 Gy, hyperthermia (43 degrees Celsius, 1 hour), and the combination of radiotherapy and hyperthermia ( 10 Gy + 43 degrees Celsius, 1 hour). FDG-microPET images were obtained by using a microPET P4 system at pretreatment and at 24 hours and 7 days after treatment. For the evaluation by FDG-microPET, tumor/muscle (T/M) ratios, retention index [RI = (T/M ratio at 120 min - T/M ratio at 60 min) / T/M ratio at 60 min], and time activity curve (TAC) were acquired. We divided the xenografts into a responder group (partial response + stable disease, n = 14) and a non-responder group (progressive disease, n = 14). The T/M ratio at 24 hours after the treatment in the responder group was decreased remarkably with that at pre-treatment (p < 0.05), while in the non-responder group it showed no significant change between the time points. The RI and TAC patterns were comparable to T/M ratios in each treatment group. T/M ratios, RI, and TAC indicated marked changes at the time point of 24 hours in the responder group, although the tumors did not show any significant change in volume at that time. Photomicrographs of sections showed that the number of viable tumor cells in the responder group decreased at 24 hours after treatment and that inflammatory cell infiltration was marked and almost all viable tumor cells had disappeared by day 7 after treatment. These results suggest that early evaluation by FDG-microPET, especially 24 hours after treatment, is useful to predict the primary effects of the treatment. Histological analysis showed that inflammatory cell infiltration at 7 days after treatment was considered to be a cause of accumulation of FDG in the tumors that showed a significant decrease in tumor cell number. This false-positive should be noted when predicting tumor response by FDG accumulation.
Tài liệu tham khảo
Kubota K, Matsuzawa T, Fujiwara T, Ito M, Hatazawa J, Ishiwata K, et al. Differential diagnosis of lung tumor with positron emission tomography: a prospective study.J Nucl Med 990; 31:1927–1932.
Di Chiro G. Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors: a powerful diagnostic and prognostic tool.Invest Radiol 1987; 22:360–371.
Slosman DO, Spiliopoulos A, Couson F, Nicod L, Louis O, Lemoine R, et al. Satellite PET and lung cancer: a prospective study in surgical patients.Nucl Med Commun 1993; 14:955–961.
Gupta NC, Maloof J, Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET.J Nucl Med 1996; 37:943–948.
Demura Y, Tsuchida T, Ishizaki T, Mizuno S, Totani Y, Ameshima S, et al.18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax.J Nucl Med 2003; 44:540–548.
Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients.EurJ Nucl Med 1996; 23:1409–1415.
Torizuka T, Nakamura F, Kanno T, Futatsubashi M, Yoshikawa E, Okada H, et al. Early therapy monitoring with FDG-PET in aggressive non-Hodgkin’s lymphoma and Hodgkin’s lymphoma.Eur J Nucl Med Mol Imaging 2004; 31:22–28.
Koike I, Ohmura M, Hata M, Takahashi N, Oka T, Ogino I, et al. FDG-PET scanning after radiation can predict tumor regrowth three months later.Int J Radiat Oncol Biol Phys 2003; 57:1231–1238.
Ichiya Y, Kuwabara Y, Otsuka M, Tahara T, Yoshikai T, Fukumura T, et al. Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.J Nucl Med 1991; 32:1655–1660.
Guay C, Lepine M, Verreault J, Benard F. Prognostic value of PET using18F-FDG in Hodgkin’s disease for posttreatment evaluation.J Nucl Med 2003; 44:1225–1231.
Kostakoglu L, Goldsmith SJ. PET in assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus.J Nucl Med 2004; 45:56–68.
Yao M, Graham MM, Hoffman HT, Smith RB, Funk GF, Graham SM, et al. The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma.Int J Radiat Oncol Biol Phys 2004; 59:1001–1010.
Hicks RJ, Manus MPM, Matthews JP, Hogg A, Binns D, Rischin D, et al. Early FDG-PET imaging after radical radiotherapy for non-small-cell lung cancer: inflammatory changes in normal tissues correlate with tumor response and do not confound therapeutic response evaluation.Int J Radiat Oncol Biol Phys 2004; 60:412–418.
Gayed I, Vu T, Iyer R, Johnson M, Macapinlac H, Swanston N, et al. The role of18F-FDG PET in staging and early prediction of response to therapy of recurrent gastrointestinal stromal tumors.J Nucl Med 2004; 45:17–21.
Kubota K. From tumor biology to clinical PET: A review of positron emission tomography (PET) in oncology.Ann Nucl Med 2001; 15:471–486.
Rege SD, Chaiken L, Hoh CK, Choi Y, Lufkin R, Anzai Y, et al. Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: Quantitation with PET.Radiology 1993; 189:807–812.
Kondo S, Hosono M, Wada Y, Ishii K, Matsumura A, Takada Y, et al. Use of FDG-microPET for detection of small nodules in a rabbit model of pulmonary metastatic cancer.Ann Nucl Med 2004; 18:51–57.
Abe Y, Matsuzawa T, Fukuda H, Endo S, Yamada K, Sato T, et al. Experimental study for tumor detection using18F-2-fluoro-2-deoxy-D-glucose: imaging of rabbit VX2 tumor with single photon gamma camera.KAKU IGAKU (Jpn J Nucl Med) 1985; 22:389–391.
Oya N, Nagata Y, Ishigaki T, Abe M, Tamaki N, Magata Y, et al. Evaluation of experimental liver tumors using fluorine-18-2-fluoro-2-deoxy-D-glucose PET.J Nucl Med 1993; 34:2124–2129.
Oya N, Nagata Y, Tamaki N, Takagi T, Murata R, Magata Y, et al. FDG-PET evaluation of therapeutic effect on VX2 liver tumor.J Nucl Med 1996:37; 296–302.
Cherry SR, Shao Y, Silverman RW. MicroPET: a high resolution PET scanner for imaging small animals.IEEE Trans Nucl Sei 1997; 44:1161–1166.
Chatziioannou AF, Cherry SR, Shao Y, Silverman RW, Meadors K, Farquhar TH, et al. Performance evaluation of MicroPET: a high-resolution lutetium oxyorthosilicate PET scanner for animal imaging.J Nucl Med 1999; 40:1164–1175.
Tai YC, Chatziioannou A, Siegel S, Young J, Newport D, Goble RN, et al. Performance evaluation of microPET P4: a PET system dedicated to animal imaging.Phys Med Biol 2001; 46:1845–1862.
Weber S, Bauer A. Small animal PET: aspects of performance assessment.Eur J Nucl Med Mol Imaging 2004; 31:1545–1555.
Tatsumi M, Nakamoto Y, Traughber B, Marshall LT, Geschwind JF, Wahl RL. Initial experience in small animal tumor imaging with a clinical positron emission tomogra- phy/computed tomography scanner using 2-[F-18]Fluoro-2-deoxy-D-glucose.Cancer Res 2003; 63:6252–6257.
Kim YH, Choi BI, Cho WH, Urn S, Moon WK, Han JK, et al. Dynamic contrast-enhanced MR imaging of VX2 carcinomas after X-irradiation in rabbits.Invest Radiol 2003; 38:539–549.
Patricio MB, Soares J, Vilhena M. Morphologic and morphometric studies on tumor necrosis produced by radiotherapy, and hyperthermia singly and in combination.J Surg Oncol 1989; 42:5–10.
Nishiue T, Kojima O. Local treatment of rabbit VX2 rectal carcinoma with combined hyperthermia and intratumoral CDDP injection,lnt J Hyperthermia 1994; 10:619–626.
Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorode-oxyglucosein vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography.J Nucl Med 1992; 33:1972–1980.
Zhuang H, Pourdehnad M, Lambright ES, Yamamoto AJ, Lanuti M, Li P, et al. Dual time point18F-FDG PET imaging for differentiating malignant from inflammatory processes.J Nucl Med 2001; 42:1412–1417.
Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue.J Nucl Med 1995; 36:1301–1306.
Kubota K, Itoh M, Ozaki K, Ono S, Tashiro M, Yamaguchi K, et al. Advantage of delayed whole-body FDG-PET imaging for tumour detection.Eur J Nucl Med 2001; 28:696–703.
Hustinx R, Smith RJ, Benard F. Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck.Eur J Nucl Med 1999; 26:1345–1348.
Lodge MA, Lucas JD, Marsden PK, Cronin BF, O’Doherty MJ, Smith MA. A PET study of18F-FDG uptake in soft tissue masses.Eur J Nucl Med 1999; 26:22–30.
Nakamoto Y, Saga T, Higashi T, Ishimori T, Kobayashi H, Ishizu K, et al. Optimal scan time for evaluating pancreatic disease with positron emission tomography using F-18- fluorodeoxyglucose.Ann Nucl Med 2003; 17:421–426.
Ishimori T, Saga T, Mamede M, Kobayashi H, Higashi T, Nakamoto Y, et al. (18)F-FDG uptake in a model of inflammation: concanavalin A-mediated lymphocyte activation.J Nucl Med 2002; 43:658–663.